Consainsights logo
Reports > Life Sciences > Closed System Transfer Devices Market Report

Closed System Transfer Devices Market Size, Share, Industry Trends and Forecast to 2033

This report provides a comprehensive analysis of the Closed System Transfer Devices market, including insights into market size, growth trends, and forecasts for the years 2023 to 2033, covering key aspects like segmentation and regional insights.

Metric Value
Study Period 2023 - 2033
2023 Market Size $2.50 Billion
CAGR (2023-2033) 7.8%
2033 Market Size $5.42 Billion
Top Companies Baxter International Inc., B. Braun Melsungen AG, CareFusion, MediDose
Last Modified Date 15 Nov 2024

Closed System Transfer Devices Market Report (2023 - 2033)

Closed System Transfer Devices Market Overview

The Closed System Transfer Devices industry has been evolving rapidly, driven by innovation and improved technologies. The increasing focus on safety standards, coupled with the need to protect healthcare professionals from hazardous drug exposure, has prompted an expansion in product offerings. Key players are investing in research and development to introduce advanced systems that ensure efficient drug handling processes. The market is characterized by a mix of established players and emerging companies, creating a competitive landscape that calls for constant updates in technology and compliance with health regulations.

What is the Market Size & CAGR of Closed System Transfer Devices market in 2023?

In 2023, the Closed System Transfer Devices market is estimated to size approximately USD 5.40 billion with a projected compound annual growth rate (CAGR) of around 8.5% from 2023 to 2033. Several factors contribute to this growth, including the increasing incidence of cancer and the subsequent rise in chemotherapy treatments, leading to higher adoption of CSTDs across healthcare facilities. Furthermore, heightened regulatory efforts focusing on drug safety are expected to bolster the market, reinforcing the importance of these systems.

Closed System Transfer Devices Industry Analysis

The Closed System Transfer Devices industry has been evolving rapidly, driven by innovation and improved technologies. The increasing focus on safety standards, coupled with the need to protect healthcare professionals from hazardous drug exposure, has prompted an expansion in product offerings. Key players are investing in research and development to introduce advanced systems that ensure efficient drug handling processes. The market is characterized by a mix of established players and emerging companies, creating a competitive landscape that calls for constant updates in technology and compliance with health regulations.

Closed System Transfer Devices Market Segmentation and Scope

The Closed System Transfer Devices market is segmented based on product type, application, end-user, material, and design type. The product types include passive systems, active systems, vial-to-vial systems, syringe-based systems, and bag-based systems. Applications are mainly categorized into oncology, antiviral therapy, hormonal therapy, and others. The end-users are primarily hospitals, pharmacies, and homecare settings. The market scope is extensive, covering various segments which play vital roles in ensuring drug safety and efficacy, catering to a wide array of clinical applications.

Request a custom research report for industry.

Closed System Transfer Devices Market Analysis Report by Region

Europe Closed System Transfer Devices Market Report:

The European market is expected to increase from USD 0.80 billion in 2023 to USD 1.74 billion by 2033. Factors such as the aging population and a rise in the number of cytotoxic drugs contribute to this upsurge.

Asia Pacific Closed System Transfer Devices Market Report:

The Asia Pacific market is projected to grow from USD 0.49 billion in 2023 to USD 1.07 billion by 2033, showing significant development in healthcare infrastructure and increasing awareness of drug safety among healthcare workers.

North America Closed System Transfer Devices Market Report:

North America holds a substantial market share, anticipated to grow from USD 0.81 billion in 2023 to USD 1.76 billion by 2033. This growth is propelled by stringent healthcare regulations, high prevalence of chronic diseases, and a strong focus on drug safety among practitioners.

South America Closed System Transfer Devices Market Report:

In South America, the market size is expected to expand from USD 0.05 billion in 2023 to USD 0.10 billion by 2033, influenced by rising investments in the healthcare sector and improvements in pharmaceutical regulations.

Middle East & Africa Closed System Transfer Devices Market Report:

The Middle East and Africa market is estimated to grow from USD 0.35 billion in 2023 to USD 0.75 billion by 2033, driven by improvements in healthcare access and rising healthcare expenditure in these regions.

Request a custom research report for industry.

Closed System Transfer Devices Market Analysis By Product Type

Global Closed System Transfer Devices Market, By Product Type Market Analysis (2023 - 2033)

The Closed System Transfer Devices market by product type reveals that passive systems dominate, expected to increase from USD 2.21 billion in 2023 to USD 4.78 billion by 2033, holding an 88.21% market share. Active systems, while smaller, are also projected to grow from USD 0.29 billion to USD 0.64 billion, capturing 11.79% of the market.

Closed System Transfer Devices Market Analysis By Application

Global Closed System Transfer Devices Market, By Application Market Analysis (2023 - 2033)

By application, oncology remains the largest segment, predicted to grow from USD 1.38 billion in 2023 to USD 2.98 billion by 2033, with a steady market share of 55.06%. Other segments, including antiviral and hormonal therapies, will see growth, but oncology is expected to remain the leader due to increasing cancer cases.

Closed System Transfer Devices Market Analysis By End User

Global Closed System Transfer Devices Market, By End-User Market Analysis (2023 - 2033)

Hospitals are the largest end-user segment in the Closed System Transfer Devices market, anticipated to grow from USD 1.65 billion in 2023 to USD 3.57 billion by 2033, maintaining a consistent 65.83% market share. Pharmacies and homecare settings are also important, with expected growth in their respective segments.

Closed System Transfer Devices Market Analysis By Material

Global Closed System Transfer Devices Market, By Material Market Analysis (2023 - 2033)

The materials segment shows plastic materials leading the market, projected to grow from USD 1.65 billion in 2023 to USD 3.57 billion by 2033, keeping the same market share of 65.83%. Metal materials and other materials are smaller segments but are growing as manufacturers explore various applications.

Closed System Transfer Devices Market Analysis By Design Type

Global Closed System Transfer Devices Market, By Design Type Market Analysis (2023 - 2033)

Design type segmentation reveals that vial-to-vial systems are expected to maintain a large share, growing from USD 1.65 billion in 2023 to USD 3.57 billion by 2033 (65.83% share). Syringe based systems also represent a significant market, projected to grow from USD 0.71 billion to USD 1.54 billion.

Request a custom research report for industry.

Global Market Leaders and Top Companies in Closed System Transfer Devices Industry

Baxter International Inc.:

Baxter is a renowned healthcare company specializing in products that address complex medical needs, including advanced CSTDs that enhance safety in drug delivery.

B. Braun Melsungen AG:

B. Braun is a global leader in medical devices and solutions, focusing on closed systems for drug delivery, ensuring quality and safety in patient care.

CareFusion:

CareFusion specializes in innovative healthcare technologies, providing CSTDs that ensure safe handling of hazardous drugs, significantly contributing to overall healthcare safety.

MediDose:

MediDose is known for its commitment to medication safety, producing CSTDs aimed at minimizing risks associated with drug administration and protecting healthcare workers.

We're grateful to work with incredible clients.

Datasite
Agilent
Asten Johnson
Bio-Rad
Carl Zeiss
Dywidag
Illumina
LEK Consulting
Shell

Related Industries

    FAQs